Why the study?
Residual cardiovascular risk remains a significant challenge, motivating an evaluation of the Remnant Cholesterol-Inflammation Index on hypertension incidence and cardiovascular sequelae.
Does a high Remnant Cholesterol-Inflammation Index (RCII) increase the risk of incident hypertension and adverse cardiovascular outcomes in Chinese and UK populations?
Population
Participants from CHARLS (N = 8,650 and N = 5,022) and UK Biobank (273,122 hypertensive participants)
Comparison
High vs low Remnant Cholesterol-Inflammation Index levels
Design
Prospective cohort analysis
Key result
The highest quartile of the Remnant Cholesterol-Inflammation Index was associated with increased risks of incident hypertension (OR 1.364) and MACE (HR 1.273) compared to the lowest quartile.
Authors
Loading...
RCII may identify higher-risk patients for hypertension and MACE; hypothesis-generating and requires prospective validation before clinical use.
Cohort (n=286,794)
Yes
Does a high Remnant Cholesterol-Inflammation Index (RCII) increase the risk of incident hypertension and adverse cardiovascular outcomes in Chinese and UK populations?
Odds Ratio: 1.364 (95% CI 1.15–1.618)
p-value: p=<0.001
The Remnant Cholesterol-Inflammation Index (RCII) serves as a complementary marker for residual cardiovascular risk, predicting both incident hypertension and adverse cardiovascular events in hypertensive patients.
Wang et al. (2026) conducted a cohort in Hypertension (n=286,794). Remnant Cholesterol-Inflammation Index (RCII) vs. Lowest RCII quartile was evaluated on Incident hypertension (OR 1.364, 95% CI 1.150-1.618, p=<0.001). The highest quartile of the Remnant Cholesterol-Inflammation Index was associated with increased risks of incident hypertension (OR 1.364) and MACE (HR 1.273) compared to the lowest quartile.